Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

ThromboGenics N.V.. (3/15/18). "Press Release: ThromboGenics Business Update – FY 2017". Leuven.

Organisations Organisation ThromboGenics N.V. (Euronext Brussels: THR)
  Today Oxurion N.V. (Euronext Brussels: OXUR)
  Group Oxurion (Group)
  Organisation 2 Oncurious N.V.
  Group Oxurion (Group)
Products Product Jetrea®
  Product 2 THR-317 (ThromboGenics)
Persons Person De Haes, Patrik (ThromboGenics 200808– CEO before Roche Diagnostics)
  Person 2 Vangeersdaele, Vinciane (ThromboGenics 201711– CCO before Novartis Ophthalmics)
     


   
Record changed: 2018-09-25

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Oxurion (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top